Your browser doesn't support javascript.
loading
L-ascorbic acid: A true substrate for HIF prolyl hydroxylase?
Osipyants, Andrey I; Poloznikov, Andrey A; Smirnova, Natalya A; Hushpulian, Dmitry M; Khristichenko, Anna Yu; Chubar, Tatiana A; Zakhariants, Arpenik A; Ahuja, Manuj; Gaisina, Irina N; Thomas, Bobby; Brown, Abe M; Gazaryan, Irina G; Tishkov, Vladimir I.
Afiliación
  • Osipyants AI; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation.
  • Poloznikov AA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation. Electronic address: andrey.poloznikov@fccho-moscow.ru.
  • Smirnova NA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation.
  • Hushpulian DM; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation.
  • Khristichenko AY; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation.
  • Chubar TA; Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation.
  • Zakhariants AA; Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation.
  • Ahuja M; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Gaisina IN; Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA.
  • Thomas B; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Brown AM; Department of Anatomy and Cell Biology, New York Medical College, 15 Dana Road, Valhalla, NY 10595, USA.
  • Gazaryan IG; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation; Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation; Department of Anatomy and Cell B
  • Tishkov VI; Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation; Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences. 33, bld. 2 Leninsky Ave., Moscow 119071, Russian Federation; Innov
Biochimie ; 147: 46-54, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29289682
ABSTRACT
L-Ascorbate (L-Asc), but not D-isoascorbate (D-Asc) and N-acetylcysteine (NAC) suppress HIF1 ODD-luc reporter activation induced by various inhibitors of HIF prolyl hydroxylase (PHD). The efficiency of suppression by L-Asc was sensitive to the nature of HIF PHD inhibitor chosen for reporter activation. In particular, the inhibitors developed to compete with alpha-ketoglutarate (αKG), were less sensitive to suppression by the physiological range of L-Asc (40-100 µM) than those having a strong iron chelation motif. Challenging those HIF activators in the reporter system with D-Asc demonstrated that the D-isomer, despite exhibiting the same reducing potency with respect to ferric iron, had almost no effect compared to L-Asc. Similarly, no effect on reporter activation was observed with cell-permeable reducing agent NAC up to 1 mM. Docking of L-Asc and D-Asc acid into the HIF PHD2 crystal structure showed interference of Tyr310 with respect to D-Asc. This suggests that L-Asc is not merely a reducing agent preventing enzyme inactivation. Rather, the overall results identify L-Asc as a co-substrate of HIF PHD that may compete for the binding site of αKG in the enzyme active center. This conclusion is in agreement with the results obtained recently in cell-based systems for TET enzymes and jumonji histone demethylases, where L-Asc has been proposed to act as a co-substrate and not as a reducing agent preventing enzyme inactivation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Ascórbico / Prolil Hidroxilasas Límite: Humans Idioma: En Revista: Biochimie Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Ascórbico / Prolil Hidroxilasas Límite: Humans Idioma: En Revista: Biochimie Año: 2018 Tipo del documento: Article